World Health Organization Issues Warning Over Acute Scarcity of Weight-Loss Injections
Fewer than 10% of people that would benefit from GLP-1 drugs including Wegovy have access to them, states the global health agency as it publishes its inaugural advice on the therapies.
With more than one billion individuals worldwide currently living with obesity, it is advocating for more widespread and fairer availability to this class of drugs.
According to estimates, in excess of 2,000,000,000 will be living with obesity by 2030 without intervention.
"The latest guidelines affirms that obesity is a chronic disease that can be treated with comprehensive and continuous treatment," stated the agency's head Tedros Adhanom Ghebreyesus.
Substantial prices, insufficient output, and logistical bottlenecks are significant hurdles to broad availability to the treatments that can assist patients in reducing substantial weight, notes the body.
GLP-1 Therapy Shortage
Even under the current most optimistic outlook, the production of these medications could only cover about 100 million people – fewer than 10% of those who need them, as stated by the health organization.
The advice encourages countries and companies to expand access, by strategies like patent sharing.
The intellectual property rights on semaglutide – the main ingredient of a leading brand – is scheduled to end in a number of nations in 2026.
The Way Weight-Loss Jabs Function
GLP-1 drugs imitate a body's own hormone to slow digestion, suppress the appetite and increase feelings of fullness so users reduce food intake.
People commonly see weight reduction after several weeks of beginning the regular doses.
Research suggests patients may see weight return within a year of halting the drug, because their usual appetite come back.
Being above a healthy weight raises your risk for experiencing health problems, like diabetes, heart disease, brain attack, and specific malignancies.
Obesity concerns people in countries worldwide and was responsible for over three and a half million fatalities worldwide in 2024, as per the WHO.
